comparemela.com

Latest Breaking News On - நவீன் ஃப்ளோரின் சர்வதேச - Page 3 : comparemela.com

Tatva Chintan Pharma Chem s GMP rises to 64% as IPO opens

Tatva Chintan Pharma Chem’s GMP rises to 64% as IPO opens SECTIONS Share Synopsis Most analysts have advised investors to subscribe to the Rs 500 crore initial public offering (IPO). The price band of the issue has been fixed at Rs 1,073-1,083 a share. Bids can be made for a minimum of 13 shares and in multiples thereafter. iStock The company is going to list at a PE of 41.62 times with a market-cap of Rs 24,00.47 crore, while its peers – namely Aarti Industries and Navin Fluorine International – trade at PE values of 59.54 times and 73.95 times, respectively. Related NEW DELHI: While the frenzy over Zomato IPO hasn’t died down yet, investors and analysts are upbeat about another issue that will open on Friday and run through Tuesday: Tatva Chintan Pharma Chem.

Nitrogen Trifluoride Market Global Analytical Overview and 2021 Future Investments Key Players : Mitsui Chemicals, OCI Materials, Foosung Co

New York City, NY: Nov. 20, 2020 – Published via (Wired Release)- The worldwide Nitrogen Trifluoride Market report intensely underlines essential market fragments including types, Key developments, driving commercial centers dependent on geographical regions, key organizations, and innovations. The report provides information on the historical and current market size and the future potential of the Nitrogen Trifluoride Market. The report primarily emphasizes prominent Nitrogen Trifluoride manufacturers/companies, segments, competition, and the environment of the global Nitrogen Trifluoride industry.The outbreak of COVID-19 was the key cause for the development and acceptance of Nitrogen Trifluoride.The CAGR of the market for the coming years to 2030 has been estimated based on a complete assessment of the market with important information concerning the different segments of the sector. The report moreover Research Report is estimated to grow at the highest growth rate till 2030.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.